Below are current clinical trials.4 studies in Testicular cancer
(open studies only).
Filter this list of studies by location, status and more.
Rochester, Minn., Jacksonville, Fla.
The purpose of this study is to determine whether Nivolumab is effective in the treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn.
GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study is to collect biological samples from donors with a new diagnosis of cancer (blood and tumor tissue) and from donors who do not have a diagnosis of cancer (blood) in order to characterize the population heterogeneity in cancer and non-cancer subjects and to develop models for distinguishing cancer from non-cancer.
The goal of this study is to create and maintain a comprehensive genitourinary disease biospecimens bank consisting of tissue, kidney stones and bodily fluid (such as blood or urine, but not limited to this) samples.
This phase II trial studies how well retroperitoneal lymph node dissection (RPLND) works in treating patients with stage I-IIa testicular seminoma. The retroperitoneum is the space in the body behind the intestines that is typically the first place that seminoma spreads. RPLND is a surgery that removes lymph nodes in this area to treat testicular seminoma and may experience fewer long-term toxicities, such as a second cancer, cardiovascular disease, metabolic syndrome (pre-diabetes), or lung disease.
April 29, 2017
- Niederhuber JE, et al., eds. Testicular cancer. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed Nov. 29, 2016.
- Testicular cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Dec. 14, 2016.
- Wein AJ, et al., eds. Neoplasms of the testis. In: Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed Nov. 29, 2016.
- Testicular self-examination (TSE). Urology Care Foundation. http://www.urologyhealth.org/urology/index.cfm?article=101. Accessed Dec. 12, 2016.
- Ilic D, et al. Screening for testicular cancer. Cochrane Database of Systematic Reviews. 2011;CD007853. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007853.pub2/abstract. Accessed Dec. 16, 2016.
- Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. October, 2016.
- Cheney SM, et al. Robot-assisted retroperitoneal lymph node dissection: Technique and initial case series of 18 patients. BJU International. http://onlinelibrary.wiley.com/doi/10.1111/bju.12804/full. Accessed Dec. 16, 2016.
- Costello BA (expert opinion). Mayo Clinic, Rochester, Minn. Jan. 29, 2017.
- Steele SS, et al. Clinical manifestations, diagnosis, and staging of testicular germ cell tumors. http://www.uptodate.com/home. Accessed Nov. 29, 2016.
- Anastasiou I, et al. Synchronous bilateral testicular tumors with different histopathology. Case Reports in Urology. 2015;492183:1.
- Rovito MJ, et al. From "D" to "I": A critique of the current United States Preventive Services Task Force recommendation for testicular cancer screening. Preventive Medicine Reports. 2016;3:361.